# Peter A. Johansson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-a-johansson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,977 |
| Field | Melanoma and MAPK Pathways |
| h-index | 60 |
| i10-index | 121 |
| Last Known Institution | Queensland University of Technology |
| OpenAlex ID | https://openalex.org/A5066064493 |
| ORCID iD | https://orcid.org/0000-0001-7015-5452 |
| Works | 311 |

## Researcher papers

- [Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/dapagliflozin-and-cardiovascular-outcomes-in-type-2-diabetes/)
- [Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial](https://scholariq.org/papers/effects-of-dapagliflozin-on-development-and-progression-of-kidney-disease-in/)
- [Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus](https://scholariq.org/papers/effect-of-dapagliflozin-on-heart-failure-and-mortality-in-type-2-diabetes/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)

## Researcher university

- [Queensland University of Technology](https://scholariq.org/institutions/queensland-university-of-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.